Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 103Lymphoma 68Lymphoma, Large B-Cell, Diffuse 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Sarcoma 33Lymphoma, Non-Hodgkin 29Hodgkin Disease 28Leukemia 23Burkitt Lymphoma 22Neoplasms 19Lymphoma, Mantle-Cell 18Triple Negative Breast Neoplasms 15Multiple Myeloma 15Lymphoma, Follicular 15Lymphoma, B-Cell 14Lymphoma, Large-Cell, Anaplastic 12Carcinoma, Hepatocellular 12Breast Neoplasms, Male 11Neuroblastoma 10Recurrence 9Ovarian Neoplasms 9Neoplasm Metastasis 9Inflammatory Breast Neoplasms 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, T-Cell, Peripheral 8Lymphoma, T-Cell 8Osteosarcoma 7Fallopian Tube Neoplasms 7Urinary Bladder Neoplasms 6Liposarcoma 6

Interventions

vandetanib 7Sorafenib 6Magnetic Resonance Spectroscopy 6lenvatinib 5cabozantinib 5Sunitinib 4Iodine-131 4selpercatinib 3AZD 6244 3trametinib 2tipifarnib 2durvalumab 2dabrafenib 2alectinib 2Triiodothyronine 2Thyroxine 2Thyrotropin Alfa 2Paclitaxel 2Nivolumab 2Ipilimumab 2Fluorodeoxyglucose F18 2Everolimus 2Bortezomib 2Axitinib 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2tremelimumab 1temsirolimus 1tanespimycin 1sapanisertib 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Thyroid Neoplasms × Doxorubicin × Clear all
NCT01882816 2022-12-29

Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
27 enrolled 12 charts
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡